Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Scott Paulson reports advisory/Consultancy: Aadi, Advanced Accelerator Applications, Amgen, Astellas Pharma, AstraZeneca, Bristol Myers Squibb, Eisai, Eli Lilly, EMD Serono, Exelixis, Hutchinson MediPharma, Incyte, Ipsen, Mirati Therapeutics, Pfizer, QED Therapeutics, Servier, Stromatis Pharma; Honoraria: Cardinal Health; Research Grant/Funding (institution): AstraZeneca, Bayer, BioNTech SE, Bristol Myers Squibb, Camurus, Deciphera, Exelixis, Eli Lilly, G1 Therapeutics, Gilead Sciences, Gritstone Bio, Hutchinson MediPharma, Incyte, Innovative Cellular Therapeutics Co, Ipsen, Merck, Nucana, Regenxbio, Relay Therapeutics, Seagen, Sotio, Taiho Pharmaceutical, Tempus, Zentalis; Stock or Stock Options: Actinium Pharmaceuticals, Aptose Biosciences, Alexion Pharmaceuticals, Lynx Health, Stromatis Pharma; Travel Accommodations/Expenses: Camurus, Pfizer. Stefan D. Anker reports grants and personal fees from CSL Vifor and Abbott Vascular, and personal fees for consultancies, trial committee work and/or lectures from Actimed, Astra Zeneca, Bayer, Bioventrix, Boehringer Ingelheim, Brahms, Cardiac Dimensions, Cardior, Cordio, CVRx, Cytokinetics, Edwards, Farraday Pharmaceuticals, GSK, HeartKinetics, Impulse Dynamics, Medtronic, Novartis, Novo Nordisk, Occlutech, Pfizer, Regeneron, Relaxera, Repairon, Scirent, Sensible Medical, Servier, Vectorious, and V-Wave. Named co-inventor of 2 patent applications regarding MR-proANP (DE 102007010834 & DE 102007022367), but he does not benefit personally from the related issued patents. Javed Butler reports consulting fees from Abbott, American Regent, Amgen, Applied Therapeutic, AskBio, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cardiac Dimension, Cardiocell, Cardior, Cardiorem, CSL Bearing, CVRx, Cytokinetics, Daxor, Edwards, Element Science, Faraday, Foundry, G3P, Innolife, Impulse Dynamics, Imbria, Inventiva, Ionis, Lexicon, Lilly, LivaNova, Janssen, Medtronics, Merck, Occlutech, Owkin, Novartis, Novo Nordisk, Pfizer, Pharmacosmos, Pharmain, Pfize, Prolaio, Regeneron, Renibus, Roche, Salamandra, Sanofi, SC Pharma, Secretome, Sequana, SQ Innovation, Tenex, Tricog, Ultromics, CSL Vifor, and Zoll, and honoraria from Novartis, Boehringer Ingelheim-Lilly, Astra Zeneca, Impulse Dynamics, CSL Vifor. Muhammad Shahzeb Khan has received fees from Bayer, Novartis, and Boehringer Ingelheim. Adeena Jamil, Syed Sarmad Javaid, Markus S. Anker, and Muhammad Hanif have no disclosures to report.
PubMed
